June 19, 2009

HELIX BIOPHARMA TO PRESENT L-DOS47 ANALYTICAL METHOD DEVELOPMENT FINDINGS AT 2009 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE (PDF)

(AURORA, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) today announced that Dr. Heman Chao, chief scientific officer at Helix BioPharma Corp., will be presenting a scientific poster describing L-DOS47 analytical method development findings at the 2009 American Association of Pharmaceutical Scientists (“AAPS”) National Biotechnology Conference, which runs from June 21st to 24th at the Washington State Convention and Trade Center in Seattle, Washington.